Use of beta‐2 agonists and risk of hip/femur fracture: a population‐based case‐control study

Administration of beta‐2 agonists decreased bone mineral density in rats. But the association between bronchodilators and fracture risk has not been studied in humans.

[1]  J. Bidwell,et al.  Osteoblast Apoptosis and Bone Turnover , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  Masaki Noda,et al.  Unloading Induces Osteoblastic Cell Suppression and Osteoclastic Cell Activation to Lead to Bone Loss via Sympathetic Nervous System* , 2005, Journal of Biological Chemistry.

[3]  H. Magnussen,et al.  Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. , 1998, The European respiratory journal.

[4]  F Sturmans,et al.  Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. , 1995, Archives of internal medicine.

[5]  S. Takeshita,et al.  TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. , 2000, The Journal of clinical investigation.

[6]  E. Mälkiä,et al.  Intensity of physical activity and respiratory function in subjects with and without bronchial asthma , 1998, Scandinavian journal of medicine & science in sports.

[7]  A. Ionescu,et al.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[8]  D. Mannino,et al.  Leisure-time physical activity patterns among US adults with asthma. , 2003, Chest.

[9]  J. Pasco,et al.  β‐Adrenergic Blockers Reduce the Risk of Fracture Partly by Increasing Bone Mineral Density: Geelong Osteoporosis Study , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  W. Kraemer,et al.  Inhibited longitudinal growth of bones in young male rats by clenbuterol. , 2002, Medicine and science in sports and exercise.

[11]  B. Stricker,et al.  Current use of thiazide diuretics and prevention of femur fractures. , 1996, Journal of clinical epidemiology.

[12]  H. Kroger,et al.  Smoking and fracture risk: a meta-analysis , 2005, Osteoporosis International.

[13]  D. Sin,et al.  The risk of osteoporosis in Caucasian men and women with obstructive airways disease. , 2003, The American journal of medicine.

[14]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[15]  C. Cooper,et al.  Severity of obstructive airway disease and risk of osteoporotic fracture , 2005, European Respiratory Journal.

[16]  J. Grisso,et al.  Falls as Risk Factors for Fractures , 2001 .

[17]  R. Herings,et al.  Asthma medications and disease exacerbations: an epidemiological study as a method for asthma surveillance. , 1995, The European respiratory journal.

[18]  J. McNeil,et al.  A Pharmacokinetic Study of Carvedilol (BM 14.190) in Elderly Subjects: Preliminary Report , 1987, Journal of cardiovascular pharmacology.

[19]  L. Suva,et al.  Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. , 2003, Bone.

[20]  D. Bauer,et al.  β‐Blocker Use, BMD, and Fractures in the Study of Osteoporotic Fractures , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2000 .

[22]  P. Anderson,et al.  Pharmacokinetics of (R,S)-Albuterol after aerosol inhalation in healthy adult volunteers. , 1998, Journal of pharmaceutical sciences.

[23]  A. Boskey,et al.  Effects of propranolol on bone metabolism in the rat , 1991, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[24]  S. Greenland.  Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis , 1995, Epidemiology.

[25]  G. Neugebauer,et al.  Pharmacokinetics and Disposition of Carvedilol in Humans , 1987, Journal of cardiovascular pharmacology.

[26]  J. Woo,et al.  Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. , 2006, Bone.

[27]  P. Dargent-Molina,et al.  BETA‐BLOCKER USE, BONE MINERAL DENSITY, AND FRACTURE RISK IN OLDER WOMEN: RESULTS FROM THE EPIDEMIOLOGIE DE L'OSTÉOPOROSE PROSPECTIVE STUDY , 2005, Journal of the American Geriatrics Society.

[28]  Masaki Noda,et al.  Leptin regulation of bone resorption by the sympathetic nervous system and CART , 2005, Nature.

[29]  R. Pistelli,et al.  Correlates of osteoporosis in chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[30]  A. Parfitt,et al.  Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  T. Nakamura,et al.  Short-term treatment of recombinant murine interleukin-4 rapidly inhibits bone formation in normal and ovariectomized mice. , 1998, Bone.

[32]  R. Hubbard,et al.  Inhaled corticosteroids and hip fracture: a population-based case-control study. , 2002, American journal of respiratory and critical care medicine.

[33]  R. Schlienger,et al.  Use of β-Blockers and Risk of Fractures , 2004 .

[34]  Arndt F Schilling,et al.  Leptin Inhibits Bone Formation through a Hypothalamic Relay A Central Control of Bone Mass , 2000, Cell.

[35]  I. Reid,et al.  Effects of a β-Blocker on Bone Turnover in Normal Postmenopausal Women: A Randomized Controlled Trial , 2005 .

[36]  S. Cummings,et al.  Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. , 1995, The New England journal of medicine.

[37]  Patricia Ducy,et al.  Leptin Regulates Bone Formation via the Sympathetic Nervous System , 2002, Cell.

[38]  B. Lipworth.  Risks Versus Benefits of Inhaled β2-Agonists in the Management of Asthma , 1992 .

[39]  H. Petri,et al.  Incidence of Fractures among Epilepsy Patients: A Population‐based Retrospective Cohort Study in the General Practice Research Database , 2005, Epilepsia.

[40]  K. Lau,et al.  Bone Loss in Patients with Untreated Chronic Obstructive Pulmonary Disease Is Mediated by an Increase in Bone Resorption Associated with Hypercapnia , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  K. Khaw,et al.  An Association Between Respiratory Function and Bone Mineral Density in Women from the General Community: A Cross Sectional Study , 2002, Osteoporosis International.

[42]  B. Lipworth,et al.  Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. , 1995, Thorax.

[43]  P. Vestergaard,et al.  Fracture Risk in Perimenopausal Women Treated with Beta-Blockers , 2004, Calcified Tissue International.

[44]  Teresa To,et al.  Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people , 1998, The Lancet.

[45]  C. Benhamou,et al.  Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. , 2005, Bone.